Feng Dong, Ph.D. is a Sr. Scientist in the Foundational Immunology at AbbVie Bioresearch Center. Dr. Dong received her Ph.D. in Physics from Drexel University with an emphasis in computational biophysics. Following completion of her post-doctoral training in Washington University School of Medicine in St. Louis, Dr. Dong joined Merck Research Laboratory leading the therapeutic antibody design and engineering. In 2011, Dr. Dong moved to AbbVie Bioresearch Center to extend her research on Bi-/Multi-specific antibody discovery.
Dr. Dong has extensive experience in therapeutic antibody and novel biologics discovery. She has initiated and delivered several drug candidates into clinical trials. She is a co-author for peer reviewed articles and a co-inventor for several issued and filed US and international patents.